Neuroendocrine Tumor
📧 Sign up to get email alerts when something new happens for Neuroendocrine Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: DLL3-Targeted PET/CT in Neuroendocrine Carcinoma [NA]
A DLL3-targeted PET/CT imaging trial for DLL3-expressing neuroendocrine tumors is currently recruiting at The First Affiliated Hospital of X…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus. [Phase 3]
A Phase 3 trial is comparing radiotherapy to everolimus for somatostatin receptor-positive neuroendocrine tumors of the lung and thymus, and…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Evaluating Myelodysplastic Syndrome Risks in NET Patients Planned for Peptide Radionuclide Therapy
Clinical trial update from University Health Network, Toronto evaluating the risk of myelodysplastic syndrome and acute myeloid leukemia in …
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer [Phase 2]
A Phase 2 clinical trial is evaluating tumor-infiltrating lymphocyte immunotherapy for multiple metastatic cancers and is currently recruiti…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: CardioNETPOL National Registry of Carcinoid Heart Disease
This entry describes the CardioNETPOL national registry for carcinoid heart disease, collecting data on patients with carcinoid heart diseas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types [Phase 1, Phase 2]
This update reports a Phase 1/2 trial of atezolizumab plus tivozanib in several immunologically cold tumor types, with the study currently s…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Cohort of Well-differentiated Grade 3 Neuroendocrine Digestive Tumors
This entry reports the completion of a clinical trial cohort studying well-differentiated grade 3 neuroendocrine tumors of the digestive tra…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Study to Assess the Safety and Effectiveness of Novel Radiopharmaceutical Terbium-161 DOTATATE in Metastatic Neuroendocrine Tumors [Phase 2]
A Phase 2 clinical trial evaluating the safety and effectiveness of Terbium-161 DOTATATE for metastatic neuroendocrine tumors, currently rec…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue) [Phase 2]
A Phase 2 clinical trial evaluating guarana for fatigue in patients with neuroendocrine tumors and gynecologic cancers is currently recruiti…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors [Phase 1]
Phase 1 clinical trial update on the investigational agent BL-M14D1 for locally advanced or metastatic small cell lung cancer and a range of…
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Telotristat Ethyl for the Treatment of Carcinoid Heart Disease in Patients With Metastatic Neuroendocrine Tumor [Phase 3]
Phase 3 trial update reports results for telotristat ethyl in treating carcinoid heart disease in patients with metastatic neuroendocrine tu…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NET [Phase 2]
A Phase 2 clinical trial is evaluating retreatment with Lutathera (lutetium Lu-177 dotatate) in patients with new progression of intestinal …
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan [Phase 3]
Phase 3 open-label study evaluating [68Ga]Ga-DOTA-TATE PET imaging in patients with neuroendocrine neoplasms (and healthy volunteers) in Jap…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy [Phase 1, Phase 2]
A Phase 1/2 trial of CHM-2101, an autologous CDH17 CAR-T therapy, is evaluating safety and early efficacy in neuroendocrine tumors, colorect…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Sapu003 in Advanced mTOR-sensitive Solid Tumors [Phase 1]
Phase 1 trial update for Sapu003 in advanced mTOR-sensitive solid tumors, currently recruiting across multiple indications including metasta…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Safety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor Patients [Phase 1]
Phase 1 study of NEUK203-13 in refractory neuroendocrine tumors and extensive-stage small cell lung cancer reports safety, tolerability and …
-
EMA approval · 2026-01-22EMA Authorised: Bavencio (avelumab) — Merck Europe B.V.
The European Medicines Agency authorised a new indication for Bavencio (avelumab) for neuroendocrine tumors.
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: TheraSphere Selective Internal Radiation Therapy (SIRT) as Treatment for Neuroendocrine Tumours With Liver Mets [Phase 2]
This Phase 2 clinical trial update reports completion of the evaluation of TheraSphere selective internal radiation therapy for neuroendocri…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: A Study of Etoposide-carboplatin in Combination With Pembrolizumab and Lenvatinib Maintenance in HG-NETs [Phase 2]
A Phase 2 clinical trial is evaluating etoposide-carboplatin with pembrolizumab and lenvatinib maintenance in high-grade neuroendocrine tumo…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Comparison of Adjuvant Treatment With 177Lu-DOTATATE to Best Supportive Care in Patients After Resection of Neuroendocrine Liver Metastases [Phase 2]
Phase 2 trial evaluating adjuvant 177Lu-DOTATATE versus best supportive care after surgical resection of neuroendocrine liver metastases; th…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases [NA]
A Mayo Clinic-led clinical trial investigates breathing practices to support brain and mental health in cancer and neurodegenerative disease…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: 18F-AlF-NOTA-Octreotide PET in Neuroendocrine Neoplasms
A clinical trial is evaluating the PET imaging tracer 18F-AlF-NOTA-Octreotide for neuroendocrine tumors; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors [Phase 2]
CVM-1118 is being studied in a Phase 2 trial for advanced neuroendocrine tumors. The study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: LUTATHERA Injection General Use Result Survey
A completed clinical trial update reports general-use results for Lutathera (lutetium Lu-177 dotatate) injection in somatostatin receptor–po…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Prospective Multicenter Real-world Study of Surufatinib in Patients With Advanced Neuroendocrine Neoplasms [Phase 4]
A Phase 4 prospective real-world trial of surufatinib in patients with advanced neuroendocrine tumors or neuroendocrine neoplasms is current…